tivicay
viiv healthcare bv - dolutegravir - hiv infektioner - antivirale midler til systemisk anvendelse - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.
amiodaronhydrochlorid "2care4" 50 mg/ml injektionsvæske, opløsning
2care4 aps - amiodaronhydrochlorid - injektionsvæske, opløsning - 50 mg/ml
cordarone 100 mg tabletter
orifarm a/s - amiodaronhydrochlorid - tabletter - 100 mg
cordan 200 mg tabletter
sandoz a/s - amiodaronhydrochlorid - tabletter - 200 mg
cordarone 50 mg/ml injektionsvæske, opløsning
sanofi a/s - amiodaronhydrochlorid - injektionsvæske, opløsning - 50 mg/ml
cordarone 50 mg/ml injektionsvæske, opløsning
orifarm a/s - amiodaronhydrochlorid - injektionsvæske, opløsning - 50 mg/ml
cordarone 100 mg tabletter
sanofi a/s - amiodaronhydrochlorid - tabletter - 100 mg
cordarone 200 mg tabletter
sanofi a/s - amiodaronhydrochlorid - tabletter - 200 mg
vosevi
gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitis c kronisk - antivirale midler til systemisk anvendelse - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (se afsnit 4. 2, 4. 4 og 5.
pifeltro
merck sharp & dohme b.v. - doravirine - hiv infektioner - antivirale midler til systemisk anvendelse - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.